Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1988 Jun;47(6):458–462. doi: 10.1136/ard.47.6.458

Evaluation of disease activity in rheumatic patients by leucocyte adhesiveness/aggregation.

S Berliner 1, M Fried 1, D Caspi 1, A Weinberger 1, M Yaron 1, J Pinkhas 1, M Aronson 1
PMCID: PMC1003545  PMID: 3260093

Abstract

Previous work has shown that leucocyte adhesiveness/aggregation (LAA), as measured by the leukergy test, correlates well with disease severity in rheumatic patients. As LAA is probably a manifestation of the acute phase reaction various components of the acute phase reaction were measured in order to identify the best marker of disease activity. In addition to LAA, the following variables were measured in 79 patients with various rheumatic diseases and in 10 controls: white blood cell and platelet counts, erythrocyte sedimentation rate, haptoglobin, fibrinogen, C reactive protein, albumin, globulin, caeruloplasmin, alpha 1, alpha 2, beta, and gamma globulin, and haemoglobin concentrations. Patients were graded according to the state of their disease as mild, moderate, or severe. The extent of leucocyte adhesiveness/aggregation in peripheral blood proved to be the best laboratory variable for the grading of disease activity. Correct grading was obtained in 63% of the patients by means of the LAA, compared with 48% with C reactive protein, 41% with caeruloplasmin, 40% with haptoglobin, and 32% with haemoglobin. It is suggested that LAA of the peripheral blood during inflammation may be used as a reliable marker of disease severity.

Full text

PDF
458

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Berliner S., Abramovitz M., Kariv N., Weinberger A., Yaron M., Lavie G., Pinkhas J., Aronson M. The leukergy test in rheumatic diseases. New implications for an old test. Arthritis Rheum. 1985 Aug;28(8):899–903. doi: 10.1002/art.1780280809. [DOI] [PubMed] [Google Scholar]
  2. Berliner S., Fishelson Z., Bruhis S., Kaufman H., Pinhas J., Aronson M. The phenomenon of leukergy: induction and detection of leukocyte aggregation in whole human blood. J Lab Clin Med. 1987 May;109(5):575–582. [PubMed] [Google Scholar]
  3. Berliner S., Sclarovsky S., Lavie G., Pinkhas J., Aronson M., Agmon J. The leukergy test in patients with ischemic heart disease. Am Heart J. 1986 Jan;111(1):19–22. doi: 10.1016/0002-8703(86)90547-8. [DOI] [PubMed] [Google Scholar]
  4. Boogaerts M. A., Hammerschmidt D. E., Roelant C., Verwilghen R. L., Jacob H. S. Mechanisms of vascular damage in gout and oxalosis: crystal induced, granulocyte mediated, endothelial injury. Thromb Haemost. 1983 Aug 30;50(2):576–580. [PubMed] [Google Scholar]
  5. CLAUSS A. Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens. Acta Haematol. 1957 Apr;17(4):237–246. doi: 10.1159/000205234. [DOI] [PubMed] [Google Scholar]
  6. Fagan E. A., Dyck R. F., Maton P. N., Hodgson H. J., Chadwick V. S., Petrie A., Pepys M. B. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest. 1982 Aug;12(4):351–359. doi: 10.1111/j.1365-2362.1982.tb02244.x. [DOI] [PubMed] [Google Scholar]
  7. Hammerschmidt D. E., Bowers T. K., Lammi-Keefe C. J., Jacob H. S., Craddock P. R. Granulocyte aggregometry: a sensitive technique for the detection of C5a and complement activation. Blood. 1980 Jun;55(6):898–902. [PubMed] [Google Scholar]
  8. Harlan J. M. Leukocyte-endothelial interactions. Blood. 1985 Mar;65(3):513–525. [PubMed] [Google Scholar]
  9. Jacob H. S. Neutrophil activation as a mechanism of tissue injury. Semin Arthritis Rheum. 1983 Aug;13(1 Suppl 1):144–147. doi: 10.1016/0049-0172(83)90034-3. [DOI] [PubMed] [Google Scholar]
  10. Kariv N., Medalia O., Aronson M. Leukocyte agglomeration test to reveal bacterial infections in mice. Lab Anim Sci. 1983 Aug;33(4):361–363. [PubMed] [Google Scholar]
  11. Lentnek A. L., Schreiber A. D., MacGregor R. R. The induction of augmented granulocyte adherence by inflammation. Mediation by a plasma factor. J Clin Invest. 1976 Apr;57(4):1098–1103. doi: 10.1172/JCI108354. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Pepys M. B., Baltz M. L. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. Adv Immunol. 1983;34:141–212. doi: 10.1016/s0065-2776(08)60379-x. [DOI] [PubMed] [Google Scholar]
  13. Rate R. G. Male breast carcinoma. An analysis of four cases. J Kans Med Soc. 1977 Dec;78(12):503–505. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES